Castrop H et al: Physiology of kidney renin. Physiol Rev 2010;90:607.
Chow BS, Allen TJ: Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease. Clin Sci (Lond) 2016;130:1307.
Crowley SD, Coffman TM: Recent advances involving the renin-angiotensin system. Exp Cell Res 2012;318:1049.
Damkjaer M et al: Renal renin secretion as regulator of body fluid homeostasis. Pflugers Archiv Eur J Physiol 2013;465:153.
Danser AH: The role of the (pro)renin receptor in hypertensive disease. Am J Hypertens 2015;28:1187.
Friis UG et al: Regulation of renin secretion by renal juxtaglomerular cells. Eur J Physiol 2013;465:25.
Harel Z et al: The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: Systematic review and meta-analysis. BMJ 2012;344:e42.
Karnik SS et al: International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin receptors: Interpreters of pathophysiological angiotensinergic stimuli [corrected]. Pharmacol Rev 2015;67:754.
Kim SM, Briggs JP, Schnermann J: Convergence of major physiological stimuli for renin release on the Gs-alpha/cyclic adenosine monophosphate signaling pathway. Clin Exp Nephrol 2012;16:17.
Kurtz A: Renin release: Sites, mechanisms, and control. Annu Rev Physiol 2011; 73:377.
McMurray JJ et al: Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010;362:1477.
Nguyen G: Renin, (pro)renin and receptor: An update. Clin Sci (Lond) 2011; 120:169.
Zheng Z et al: A systematic review and meta-analysis of aliskiren and angiotensin receptor blockers in the management of essential hypertension. J Renin Angiotensin Aldosterone Syst 2011;12:102.
Treprostinil Tyvaso, Remodulin
Bork K: A decade of change: Recent developments in pharmacotherapy of hereditary angioedema (HAE). Clin Rev Allergy Immunol 2016;51:183.
Cicardi M et al: Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med 2010;363:523.
Cicardi M et al: Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010;363:532.
Pathak M et al: Structure of plasma and tissue kallikreins. Thromb Haemost 2013;109:423.
Taddei S, Bortolotto L: Unraveling the pivotal role of bradykinin in ACE inhibitor activity. Am J Cardiovasc Drugs 2016;16:309.
Asfar P et al: Selepressin in septic shock: A step toward decatecholaminization? Crit Care Med 2016;44:234.